PROBLEM: Sound-therapy trials are easy to bias: a patient who hears music or feels vibration knows they are being treated, so unblinded trials overstate the benefit — and without a placebo-control standard, a trial with no sham arm is quoted as if it had one.
SOLUTION: A placebo-control standard for sound-therapy trials that requires every cited trial to name its control: sham device, placebo sound, or no treatment — and records the quality consequence when the control is missing, following the Cochrane reviews' own downgrades for risk of bias. A trial without a sham control is graded as weaker evidence, not as equal evidence.
EVIDENCE BASIS: DOCUMENTED — Cochrane reviews of music therapy and TENS downgrade certainty for risk of bias where blinding is absent or controls are mixed (e.g., TENS period-pain review pools placebo and no-treatment arms; dementia music review notes all studies at high risk of performance bias). Sham-controlled design is the standard that separates effect from expectation.
| Idea priority | Low |
| Needed By | Not sure -- Just thought it was cool |
By clicking the "Post Comment" or "Submit Idea" button, you are agreeing to the IBM Ideas Portal Terms of Use.
Do not place IBM confidential, company confidential, or personal information into any field.